digital banking system- Top Top stories

Dezhe Medicine is a listed company in science and technology innovation board, and it is an innovation-driven biomedical company with global competitiveness. Therefore, its refinancing has been approved by the Shanghai Stock Exchange, which also shows that the supervision is tolerant of companies with core technology and hard power. Although it may not be ideal financially for the time being, it has broad prospects and great imagination, which is worthy of support.At present, I am optimistic about tomorrow's trend. It is stronger than expected to maintain this trend today. Although the index has not increased much, the short-term trend at the daily level is still upward, and the quantity can be maintained. Should it continue to rise? The probability of continuing to close up tomorrow is still very high, and the short-term trend of the 60-minute level is to go well again.Federal Reserve's December Outlook

This afternoon, the Government of the Hong Kong Special Administrative Region welcomed the passage of the Stamp Duty Legislation (Miscellaneous Amendments) Bill 2024 by the Legislative Council, which exempted the transfer of shares or units of real estate investment trusts and the securities distribution business of option makers, and revised the stamp duty collection arrangements under the paperless securities market system in Hong Kong.On the evening of December 10th, Google released a new generation of quantum computing chip Willow, which caused a great sensation in the global scientific and technological community. It is reported that this is a major breakthrough in the field of quantum computing-this field is regarded as the next technological frontier of many technology companies.

Dizhe Pharmaceutical announced that the company's private placement plan has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article".At present, the market has also reached a very critical stage. If the large-cap stocks of heavyweights don't make efforts to push the index to a higher level, the short-term risk is relatively large in terms of the current position of CSI 2000 and micro-cap stocks. For example, the CSI 2000 index closed at 2635.58 today, and the high point in January 2022 was 2700.24, which is very close. It has not crossed this high point for more than two years, which shows that the pressure here is very great. If the market does not continue to launch upward, then it is impossible to complete an effective breakthrough by relying on small-cap stocks themselves, and it is impossible to get out of the independent market. Once the platform is effectively established, a larger level of space will be opened, and small-cap stocks will hopefully step out of a larger level of market. Otherwise, this wave of sharp rebound may stop here.At present, there is nothing wrong with the medium and long-term trend, so don't worry too much. Strategically, we will continue to watch more. Tactically, we will follow the trend and take the initiative step by step.